XML 94 R81.htm IDEA: XBRL DOCUMENT v3.25.1
FINANCIAL INSTRUMENTS - Schedule of Income Statement (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Derivative Instruments, Gain (Loss)    
Net sales $ 3,515 $ 3,595
Cost of sales 2,876 2,951
Selling, general and administrative expenses 315 329
Other comprehensive income (loss) 59 (55)
Gain (loss) recognized in other comprehensive income (1) 18
Foreign currency | Cash flow hedging | Gain (loss) reclassified from AOCI to income    
Derivative Instruments, Gain (Loss)    
Net sales 0 0
Cost of sales (2) 0
Selling, general and administrative expenses $ (2) $ 10